Company Filing History:
2 out of 1,743 
1 out of 1 
1 out of 3 Years Active: 2015-2016
Title: Céline Greco: Innovator in Cancer Management
Introduction
Céline Greco is a notable inventor based in Villejuif, France. He has made significant contributions to the field of cancer management, particularly through his innovative approaches targeting the Co-029 protein. With a total of 2 patents, Greco's work is paving the way for advancements in cancer treatment and prevention.
Latest Patents
Céline Greco's latest patents focus on methods for cancer management targeting Co-029. The disclosures relate to a Co-029 inhibitor designed to inhibit the migration of cancer cells that express Co-029. These patents detail the use of the Co-029 inhibitor for treating cancer and preventing cancer metastasis. Additionally, they include pharmaceutical compositions comprising the inhibitor and provide Co-029 antibodies. The patents also outline methods for predicting a patient's response to treatment with a Co-029 inhibitor, diagnosing cancer in patients, and predicting survival rates in cancer patients.
Career Highlights
Throughout his career, Céline Greco has worked with esteemed institutions such as the Institut National de la Santé et de la Recherche Médicale and Université de Paris XI Paris Sud. His research has significantly impacted the understanding and management of cancer, showcasing his dedication to improving patient outcomes.
Collaborations
Céline Greco has collaborated with notable colleagues, including Eric Rubinstein and François Le Naour. These partnerships have further enhanced his research and innovation in the field of cancer management.
Conclusion
Céline Greco's contributions to cancer management through his innovative patents and collaborations highlight his commitment to advancing medical science. His work continues to inspire and pave the way for future developments in cancer treatment.